Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients
- Author
- NASHAN, Björn1
[1] Department of Hepatobiliary Surgery and Visceral Transplantation, University Medical Center Eppendorf, Hamburg, Germany - Conference title
- Innovations in Transplantation Medicine: Proceedings of the annual multidisciplinary Heidelberg Transplant Symposia, Heidelberg, October 2011
- Conference name
- Annual Multidisciplinary Heidelberg Transplant Symposia (Heidelberg 2011-10)
- Author (monograph)
- MEHRABI, A (Editor); BÜCHLER, M. W (Editor); ZEIER, M (Editor); SCHEMMER, P (Editor)
- Source
Clinical transplantation. 2013, Vol 27, pp 16-29, 14 p ; SUP25 ; ref : 72 ref
- ISSN
- 0902-0063
- Scientific domain
- Graft, transplantation
- Publisher
- Wiley, Hoboken, NJ
- Publication country
- United States
- Document type
- Conference Paper
- Language
- English
- Author keyword
- antithymocyte globulin basiliximab calcineurin inhibitors daclizumab everolimus induction kidney transplantation mTOR inhibitors minimization sirolimus
- Keyword (fr)
- Antibactérien Antibiotique Anticancéreux Basiliximab Chimiothérapie Daclizumab De novo Déclenchement Evérolimus Exposition Globuline antithymocyte Homme Homotransplantation Immunodépresseur Immunomodulateur Immunothérapie Induction Inhibiteur de la calcineurine Inhibition Malade Médecine Rein Sirolimus Traitement induction Transplantation rénale Anti-CD25 Antigène CD25 Inhibiteur mTOR Anticorps monoclonal Appareil urinaire Chirurgie Inhibiteur synthèse protéique Lactone Macrocycle Macrolide Traitement
- Keyword (en)
- Antibacterial agent Antibiotic Antineoplastic agent Basiliximab Chemotherapy Daclizumab De novo Triggering Everolimus Exposure Antithymocyte globulin Human Homotransplantation Immunosuppressive agent Immunomodulator Immunotherapy Induction Calcineurin inhibitor Inhibition Patient Medicine Kidney Sirolimus Induction treatment Kidney transplantation Monoclonal antibody Urinary system Surgery Protein synthesis inhibitor Lactone Macrocycle Macrolide Treatment
- Keyword (es)
- Antibacteriano Antibiótico Anticanceroso Basiliximab Quimioterapia Daclizumab De novo Inducción Everolimus Exposición Globulina antitimocita Hombre Homotrasplante Inmunodepresor Inmunomodulador Inmunoterapia Inducción Inhibidor calcineurina Inhibición Enfermo Medicina Riñón Sirolimús Tratamiento inductivo Trasplante de riñón Anticuerpo monoclonal Aparato urinario Cirugía Inhibidor síntesis proteica Lactona Macrociclo Macrólido Tratamiento
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A06 Fundamental immunology / 002A06F Tissue, organ and graft immunology
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S02 Antibacterial agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B25 Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases / 002B25H Surgery of the urinary system
- Discipline
- Fundamental immunology Pharmacological treatments Surgery. Transplants, organs and tissues grafting. Graft pathologies
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27712191
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/ctr.12156 
https://dx.doi.org/10.1111/ctr.12156
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1111\/ctr.12156\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:117:\"Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical transplantation\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. transplant\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"16\";s:8:\"\u0000*\u0000epage\";s:2:\"29\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0902-0063\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"NASHAN\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Bj\u00f6rn\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:5:\"SUP25\";s:9:\"\u0000*\u0000btitle\";s:141:\"Innovations in Transplantation Medicine: Proceedings of the annual multidisciplinary Heidelberg Transplant Symposia, Heidelberg, October 2011\";s:8:\"\u0000*\u0000title\";s:117:\"Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"14\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1111\/ctr.12156\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:117:\"Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical transplantation\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. transplant\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"16\";s:8:\"\u0000*\u0000epage\";s:2:\"29\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0902-0063\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"NASHAN\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Bj\u00f6rn\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:5:\"SUP25\";s:9:\"\u0000*\u0000btitle\";s:141:\"Innovations in Transplantation Medicine: Proceedings of the annual multidisciplinary Heidelberg Transplant Symposia, Heidelberg, October 2011\";s:8:\"\u0000*\u0000title\";s:117:\"Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"14\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:17:\"10.1111\/ctr.12156\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1111\/ctr.12156\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:117:\"Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical transplantation\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. transplant\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"16\";s:8:\"\u0000*\u0000epage\";s:2:\"29\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0902-0063\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"NASHAN\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Bj\u00f6rn\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:5:\"SUP25\";s:9:\"\u0000*\u0000btitle\";s:141:\"Innovations in Transplantation Medicine: Proceedings of the annual multidisciplinary Heidelberg Transplant Symposia, Heidelberg, October 2011\";s:8:\"\u0000*\u0000title\";s:117:\"Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"14\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1111\/ctr.12156\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:117:\"Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical transplantation\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. transplant\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"16\";s:8:\"\u0000*\u0000epage\";s:2:\"29\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0902-0063\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"NASHAN\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Bj\u00f6rn\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:5:\"SUP25\";s:9:\"\u0000*\u0000btitle\";s:141:\"Innovations in Transplantation Medicine: Proceedings of the annual multidisciplinary Heidelberg Transplant Symposia, Heidelberg, October 2011\";s:8:\"\u0000*\u0000title\";s:117:\"Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"14\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1111\/ctr.12156\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:117:\"Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical transplantation\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. transplant\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:2:\"16\";s:8:\"\u0000*\u0000epage\";s:2:\"29\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0902-0063\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"NASHAN\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Bj\u00f6rn\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:5:\"SUP25\";s:9:\"\u0000*\u0000btitle\";s:141:\"Innovations in Transplantation Medicine: Proceedings of the annual multidisciplinary Heidelberg Transplant Symposia, Heidelberg, October 2011\";s:8:\"\u0000*\u0000title\";s:117:\"Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"14\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
